Exact Mass: 368.3039

Exact Mass Matches: 368.3039

Found 325 metabolites which its exact mass value is equals to given mass value 368.3039, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cortol

(3R,5R,8S,9S,10S,11S,13S,14S,17R)-17-[(1S)-1,2-dihydroxyethyl]-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,11,17-triol

C21H36O5 (368.2563)


Involved in C21-Steroid hormone metabolism. [HMDB] Involved in C21-Steroid hormone metabolism.

   

Carboprost Tromethamine

1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13E,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-Oic acid

C21H36O5 (368.2563)


Carboprost Tromethamine is only found in individuals that have used or taken this drug. It is a nonsteroidal abortifacient agent that is effective in both the first and second trimesters of pregnancy. [PubChem]Carboprost is a synthetic prostaglandin. It binds the prostaglandin E2 receptor, causing myometrial contractions, casuing the induction of labour or the expulsion of the placenta. Prostaglandins occur naturally in the body and act at several sites in the body including the womb (uterus). They act on the muscles of the womb, causing them to contract. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D012102 - Reproductive Control Agents > D010120 - Oxytocics C78568 - Prostaglandin Analogue

   
   

Misoprostol

9-oxo-11α,16-dihydroxy-16-methyl-prost-13E-en-1-oic acid

C21H36O5 (368.2563)


   

(E)-26,27-Dinorergosta-4,22-dien-3-one

2,15-dimethyl-14-[(3E)-5-methylhex-3-en-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C26H40O (368.3079)


(E)-26,27-Dinorergosta-4,22-dien-3-one is found in crustaceans. (E)-26,27-Dinorergosta-4,22-dien-3-one is a constituent of dried prawns (Nematopalaemon tenuipes).

   

(R)-3,4-Dihydro-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol

2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol

C25H36O2 (368.2715)


(R)-3,4-Dihydro-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol is found in cereals and cereal products. (R)-3,4-Dihydro-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol is isolated from rice bran. Antitumour agent and antioxidan Isolated from rice bran. Antitumour agent and antioxidant. (R)-3,4-Dihydro-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol is found in cereals and cereal products.

   

1,1'-[1,13-Tridecanediylbis(oxy)]bisbenzene

1,1-[1,13-Tridecanediylbis(oxy)]bisbenzene, 9ci

C25H36O2 (368.2715)


1,1-[1,13-Tridecanediylbis(oxy)]bisbenzene is found in nuts. 1,1-[1,13-Tridecanediylbis(oxy)]bisbenzene is isolated from the leaves of Arachis hypogaea (peanut) infected with Puccinia arachidis. Isolated from the leaves of Arachis hypogaea (peanut) infected with Puccinia arachidis. 1,1-[1,13-Tridecanediylbis(oxy)]bisbenzene is found in nuts.

   

12'-Apo-b-carotene-3,12'-diol

4-[(1E,3Z,5E,7E,9E,11Z)-13-hydroxy-3,7,12-trimethyltrideca-1,3,5,7,9,11-hexaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol

C25H36O2 (368.2715)


12-Apo-b-carotene-3,12-diol is found in fruits. 12-Apo-b-carotene-3,12-diol is a constituent of peaches (Prunus persica) Constituent of peaches (Prunus persica). 12-Apo-b-carotene-3,12-diol is found in fruits.

   

gamma-Eudesmol rhamnoside

2-{[2-(4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-yl]oxy}-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


gamma-Eudesmol rhamnoside is a constituent of fruits of Cananga odorata (ylang ylang). Constituent of fruits of Cananga odorata (ylang ylang)

   

beta-Cortol

(1S,2S,5R,7R,10S,11S,14R,15S,17S)-14-[(1R)-1,2-dihydroxyethyl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14,17-triol

C21H36O5 (368.2563)


beta-Cortol is a normal androgen metabolite present in adults. It has been found in the urine of infants as well. Beta-Cortol is the 5b enantiomer of beta-allocortol. Beta-cortol levels are significantly higher in premenopausal women with leiomyomas than in age-matched healthy premenopausal control women. Uterine leiomyomas are tumors closely associated with estrogen levels and it has been noted that the development of leiomyomas depends on the condition of menstruation, perimenopause and pregnancy. (PMID: 14698830, 14616886, 14643447, 15635046, 14709852) [HMDB] beta-Cortol is a normal androgen metabolite present in adults. It has been found in the urine of infants as well. beta-Cortol is the 5beta enantiomer of beta-allocortol. beta-Cortol levels are significantly higher in premenopausal women with leiomyomas than in age-matched healthy premenopausal control women. Uterine leiomyomas are tumours closely associated with estrogen levels and it has been noted that the development of leiomyomas depends on the condition of menstruation, perimenopause, and pregnancy (PMID: 14698830, 14616886, 14643447, 15635046, 14709852).

   

Octadecyl fumarate

(2Z)-4-(octadecyloxy)-4-oxobut-2-enoic acid

C22H40O4 (368.2926)


Na salt is a dough conditioner, stabilising agent, conditioning agent for dehydrated potato and other processed foods. Na salt is a dough conditioner, stabilising agent, conditioning agent for dehydrated potato and other processed foods

   

Oleoylcholine

trimethyl({2-[(9Z)-octadec-9-enoyloxy]ethyl})azanium

C23H46NO2+ (368.3528)


Oleoylcholine, also known as choline oleic acid, belongs to the class of organic compounds known as acyl cholines. These are acylated derivatives of choline. Choline or 2-hydroxy-N,N,N-trimethylethanaminium is a quaternary ammonium salt with the chemical formula (CH3)3N+(CH2)2OH. Oleoylcholine has been identified in blood (PMID: 31396400).

   

(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene

7a-methyl-1-(6-methylheptan-2-yl)-4-[2-(2-methylidenecyclohexylidene)ethylidene]-octahydro-1H-indene

C27H44 (368.3443)


   

2,2'-Methylenebis(4-ethyl-6-tert-butylphenol)

2-tert-butyl-6-[(3-tert-butyl-5-ethyl-2-hydroxyphenyl)methyl]-4-ethylphenol

C25H36O2 (368.2715)


   

Carboprost

7-[3,5-dihydroxy-2-(3-hydroxy-3-methyloct-1-en-1-yl)cyclopentyl]hept-5-enoic acid

C21H36O5 (368.2563)


   

Didesmethyl tocotrienol

2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C25H36O2 (368.2715)


   

Misoprostol acid

7-[3-hydroxy-2-(4-hydroxy-4-methyloct-1-en-1-yl)-5-oxocyclopentyl]heptanoic acid

C21H36O5 (368.2563)


   

Prostaglandin F2alpha methyl ester

Methyl 7-[3,5-dihydroxy-2-(3-hydroxyoct-1-en-1-yl)cyclopentyl]hept-5-enoic acid

C21H36O5 (368.2563)


   

Proterguride

3,3-diethyl-1-{6-propyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl}urea

C22H32N4O (368.2576)


   

MG(18:2(10E,12Z)+=O(9)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C21H36O5 (368.2563)


MG(18:2(10E,12Z)+=O(9)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(18:2(9Z,11E)+=O(13)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C21H36O5 (368.2563)


MG(18:2(9Z,11E)+=O(13)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(18:3(10,12,15)-OH(9)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C21H36O5 (368.2563)


MG(18:3(10,12,15)-OH(9)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(18:3(9,11,15)-OH(13)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C21H36O5 (368.2563)


MG(18:3(9,11,15)-OH(13)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/18:2(10E,12Z)+=O(9)/0:0)

1,3-Dihydroxypropan-2-yl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C21H36O5 (368.2563)


MG(0:0/18:2(10E,12Z)+=O(9)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/18:2(9Z,11E)+=O(13)/0:0)

1,3-Dihydroxypropan-2-yl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C21H36O5 (368.2563)


MG(0:0/18:2(9Z,11E)+=O(13)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/18:3(10,12,15)-OH(9)/0:0)

1,3-Dihydroxypropan-2-yl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C21H36O5 (368.2563)


MG(0:0/18:3(10,12,15)-OH(9)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/18:3(9,11,15)-OH(13)/0:0)

1,3-Dihydroxypropan-2-yl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C21H36O5 (368.2563)


MG(0:0/18:3(9,11,15)-OH(13)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

docosanedioate

Docosanedioic acid(2-)

C22H40O4 (368.2926)


Docosanedioate, also known as docosanedioic acid or c22:0-dca(2-), is a member of the class of compounds known as very long-chain fatty acids. Very long-chain fatty acids are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Docosanedioate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Docosanedioate can be found in a number of food items such as pomes, green zucchini, pot marjoram, and rowal, which makes docosanedioate a potential biomarker for the consumption of these food products. Docosanedioic acid is a dicarboxylic acid with the linear formula HOOC(CH2)20COOH .

   

Secosubamolide A

Secosubamolide A

C22H40O4 (368.2926)


   

Variecolin

Variecolin

C25H36O2 (368.2715)


A natural product found particularly in Phoma and Aspergillus variecolor.

   

Protoconstipatic acid

Protoconstipatic acid

C21H36O5 (368.2563)


   

Betaenone B

Betaenone B

C21H36O5 (368.2563)


   

DTXSID40920834

DTXSID40920834

C21H36O5 (368.2563)


   

Antioxidant 425

Antioxidant 425

C25H36O2 (368.2715)


   

ACMC-20mflt

ACMC-20mflt

C21H36O5 (368.2563)


   

Tomentogenin|Tomentogenin (5alpha-Dihydro-utendin)

Tomentogenin|Tomentogenin (5alpha-Dihydro-utendin)

C21H36O5 (368.2563)


   
   

(1beta,4alpha,5beta,6alpha,7alpha,10alpha)-10-Aromadendranol

(1beta,4alpha,5beta,6alpha,7alpha,10alpha)-10-Aromadendranol

C21H36O5 (368.2563)


   

14?鈥?Alcohol-Isomuronic acid

14?鈥?Alcohol-Isomuronic acid

C21H36O5 (368.2563)


   

14-Oxotricosanoic acid

14-Oxotricosanoic acid

C23H44O3 (368.329)


   

tetrahydro-2-(14-hydroxypentadecyl)-4-methylene-5-oxo-3-furancarboxylic acid

tetrahydro-2-(14-hydroxypentadecyl)-4-methylene-5-oxo-3-furancarboxylic acid

C21H36O5 (368.2563)


   

methyl-2alpha,3alpha,9beta-trihydroxy-9-epi-labd-13(E)-en-15-oate

methyl-2alpha,3alpha,9beta-trihydroxy-9-epi-labd-13(E)-en-15-oate

C21H36O5 (368.2563)


   

Cerorubenic acid III

Cerorubenic acid III

C25H36O2 (368.2715)


   

(-)-dihydropertusaric acid|(-)589-Pertusarinic acid|(2S,3S,4S)-2,3,4,5-tetrahydro-4-methyl-5-oxo-2-(14-oxopentadecyl)furan-3-carboxylic acid|(3S,4S,5S)-4-carboxy-3-methyl-2-oxo-5-(14-oxopentadecyl)tetrahydrofuran

(-)-dihydropertusaric acid|(-)589-Pertusarinic acid|(2S,3S,4S)-2,3,4,5-tetrahydro-4-methyl-5-oxo-2-(14-oxopentadecyl)furan-3-carboxylic acid|(3S,4S,5S)-4-carboxy-3-methyl-2-oxo-5-(14-oxopentadecyl)tetrahydrofuran

C21H36O5 (368.2563)


   

coscinafuran

coscinafuran

C25H36O2 (368.2715)


   

erythrophloin D

erythrophloin D

C25H36O2 (368.2715)


   

beta-D-Fucopyranoside-1(10)-Spirovetiven-11-ol

beta-D-Fucopyranoside-1(10)-Spirovetiven-11-ol

C21H36O5 (368.2563)


   

Pretomexanthol

Pretomexanthol

C21H36O5 (368.2563)


   

3-hydroxy-2-(hydroxymethyl)-4-(14-methylpentadecanoyl)-2H-furan-5-one

3-hydroxy-2-(hydroxymethyl)-4-(14-methylpentadecanoyl)-2H-furan-5-one

C21H36O5 (368.2563)


   
   

(22E)-27-norcholesta-5,7,22-trien-3beta-ol

(22E)-27-norcholesta-5,7,22-trien-3beta-ol

C26H40O (368.3079)


   

(3beta,22E)-24-Norcholesta-5,7,22-trien-3-ol

(3beta,22E)-24-Norcholesta-5,7,22-trien-3-ol

C26H40O (368.3079)


   

Dinoprost methyl

Dinoprost methyl

C21H36O5 (368.2563)


   

4,5-cis-4.5-dihydroxy-5-(1-hydroxyheptadecyl)-2-cyclopenten-1-one|hygrophoron B16|hygrophorone B16

4,5-cis-4.5-dihydroxy-5-(1-hydroxyheptadecyl)-2-cyclopenten-1-one|hygrophoron B16|hygrophorone B16

C22H40O4 (368.2926)


   

22,29,30-TRISNORNEOHOP-13(18)-ENE

22,29,30-TRISNORNEOHOP-13(18)-ENE

C27H44 (368.3443)


   

RK-682, Streptomyces sp.

RK-682, Streptomyces sp.

C21H36O5 (368.2563)


   

agallochin M|methyl ent-13-epi-8,13-epoxy-4,6alpha-dihydroxy-3,4-secolabd-14-en-3-oate

agallochin M|methyl ent-13-epi-8,13-epoxy-4,6alpha-dihydroxy-3,4-secolabd-14-en-3-oate

C21H36O5 (368.2563)


   

Methyl 13-oxodocosanoate

Methyl 13-oxodocosanoate

C23H44O3 (368.329)


   

26,27-Bisnorcholest-5-en-23-yn-3beta-ol-7-one|Gelliusterol B

26,27-Bisnorcholest-5-en-23-yn-3beta-ol-7-one|Gelliusterol B

C25H36O2 (368.2715)


   

12-Ketobehenic acid methyl ester

12-Ketobehenic acid methyl ester

C23H44O3 (368.329)


   

(-)-PGE1 methyl ester|(-)-prostaglandin E1 methyl ester|methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxy-1-octenyl]-5-oxocyclopentyl]heptanoate|Methyl prostaglandin E1|PGE1 methyl ester|prostaglandin E1 methyl ester

(-)-PGE1 methyl ester|(-)-prostaglandin E1 methyl ester|methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxy-1-octenyl]-5-oxocyclopentyl]heptanoate|Methyl prostaglandin E1|PGE1 methyl ester|prostaglandin E1 methyl ester

C21H36O5 (368.2563)


   

15-Ketobehenic acid methyl ester

15-Ketobehenic acid methyl ester

C23H44O3 (368.329)


   

6-epi-ophiobolin N

6-epi-ophiobolin N

C25H36O2 (368.2715)


   

(2S)-1-O-(9-oxo-10(E),12(E)-octadecadienoyl) glycerol

(2S)-1-O-(9-oxo-10(E),12(E)-octadecadienoyl) glycerol

C21H36O5 (368.2563)


   

halichonadin J

halichonadin J

C24H36N2O (368.2827)


   

19-nor-cholesta-1,3,5(10)-trien-3-ol|19-nor-Delta1,3,5(10)-cholestatrien-3-ol|19-Norcholesta-1,3,5(10)-trien-3-ol|19-norcholesta-1,3,5(10)trien-3-ol|3-Hydroxy-19-norcholesta-1,3,5(10)-triene

19-nor-cholesta-1,3,5(10)-trien-3-ol|19-nor-Delta1,3,5(10)-cholestatrien-3-ol|19-Norcholesta-1,3,5(10)-trien-3-ol|19-norcholesta-1,3,5(10)trien-3-ol|3-Hydroxy-19-norcholesta-1,3,5(10)-triene

C26H40O (368.3079)


   

2R,4R-diacetoxy-1-hydroxy-n-heptadeca-16-yne

2R,4R-diacetoxy-1-hydroxy-n-heptadeca-16-yne

C21H36O5 (368.2563)


   

sinularone I

sinularone I

C21H36O5 (368.2563)


   

plakortide S

plakortide S

C22H40O4 (368.2926)


   

1-[nonadeca-(9Z,12Z)-dienoyl]-sn-glycerol

1-[nonadeca-(9Z,12Z)-dienoyl]-sn-glycerol

C22H40O4 (368.2926)


   

1,2R-diacetoxy-4R-hydroxy-n-heptadeca-16-yne

1,2R-diacetoxy-4R-hydroxy-n-heptadeca-16-yne

C21H36O5 (368.2563)


   

1,4R-diacetoxy-2R-hydroxy-n-heptadec-16-yne

1,4R-diacetoxy-2R-hydroxy-n-heptadec-16-yne

C21H36O5 (368.2563)


   

(4S,5S,7R,10S)-Eudesm-11-en-4-ol beta-D-fucopyranoside

(4S,5S,7R,10S)-Eudesm-11-en-4-ol beta-D-fucopyranoside

C21H36O5 (368.2563)


   

2-Hydroxy-14-tricosenoic acid

2-Hydroxy-14-tricosenoic acid

C23H44O3 (368.329)


   

(-)-papuamine|Papuamine

(-)-papuamine|Papuamine

C25H40N2 (368.3191)


   

Chaetomellic acid E

Chaetomellic acid E

C21H36O5 (368.2563)


   

microcarbonin A

microcarbonin A

C25H36O2 (368.2715)


   

Desacyl-kondurangogenin C; Dihydrodrevogenin D

Desacyl-kondurangogenin C; Dihydrodrevogenin D

C21H36O5 (368.2563)


   

14-Ketobehenic acid methyl ester

14-Ketobehenic acid methyl ester

C23H44O3 (368.329)


   

emericolin D

emericolin D

C25H36O2 (368.2715)


   

5-(7,10,13,16-nonadecatetraenyl)-1,3-benzenediol

5-(7,10,13,16-nonadecatetraenyl)-1,3-benzenediol

C25H36O2 (368.2715)


   

(2SR,3RS)-methyl 3-hydroxy-2-((Z)-hexadec-7-enyl)-4-oxopentanoate

(2SR,3RS)-methyl 3-hydroxy-2-((Z)-hexadec-7-enyl)-4-oxopentanoate

C22H40O4 (368.2926)


   

Cerorubenic acid I|Cerorubenic acid II

Cerorubenic acid I|Cerorubenic acid II

C25H36O2 (368.2715)


   

11-Ketobehenic acid methyl ester

11-Ketobehenic acid methyl ester

C23H44O3 (368.329)


   

11,12-didehydro-13-oxo-plakortide Q

11,12-didehydro-13-oxo-plakortide Q

C21H36O5 (368.2563)


   

.delta.(Sup3,5)-Cholestadiene

.delta.(Sup3,5)-Cholestadiene

C27H44 (368.3443)


   

C25H36O2_Dicyclopenta[a,d]cycloocten-3(3aH)-one, 7-[(2Z)-1,5-dimethyl-2,4-hexadien-1-yl]-6,6a,7,8,9,9a,10,10a-octahydro-4-(hydroxymethyl)-1,9a-dimethyl-, (4E,6aS,7R,9aR,10aS)

NCGC00385006-01_C25H36O2_Dicyclopenta[a,d]cycloocten-3(3aH)-one, 7-[(2Z)-1,5-dimethyl-2,4-hexadien-1-yl]-6,6a,7,8,9,9a,10,10a-octahydro-4-(hydroxymethyl)-1,9a-dimethyl-, (4E,6aS,7R,9aR,10aS)-

C25H36O2 (368.2715)


   

Dihydropertusaric

Dihydropertusaric

C21H36O5 (368.2563)


   

Dihydromuronic acid

Dihydromuronic acid

C21H36O5 (368.2563)


   

Murolic acid

Murolic acid

C21H36O5 (368.2563)


   

Isomurolic acid

Isomurolic acid

C21H36O5 (368.2563)


   

Misoprostol (free acid)

9-oxo-11α,16-dihydroxy-16-methyl-prost-13E-en-1-oic acid

C21H36O5 (368.2563)


   
   

15-methyl-15(S)-PGE1

9-oxo-11R,15S-dihydroxy-15-methyl-13E-prostaenoic acid

C21H36O5 (368.2563)


   

PGF2&alpha

methyl 9S,11R,15S-trihydroxy-5Z,13E-prostadienoate

C21H36O5 (368.2563)


   

15(R)-15-methyl PGF2&alpha

9α,11α,15R-trihydroxy-15-methyl-prosta-5Z,13E-dien-1-oic acid

C21H36O5 (368.2563)


   

Carboprost

Carboprost

C21H36O5 (368.2563)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D012102 - Reproductive Control Agents > D010120 - Oxytocics C78568 - Prostaglandin Analogue

   

3-Deoxyvitamin D3

(5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene

C27H44 (368.3443)


   

didesmethyl tocotrienol

2R-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-chromen-6-ol

C25H36O2 (368.2715)


   

b-Cortol

5beta-Pregnane-3alpha,11beta,17,20beta,21-pentol 20beta-cortol

C21H36O5 (368.2563)


   

2-oxo-tricosanoic acid

2-oxo-tricosanoic acid

C23H44O3 (368.329)


   

22-oxo-tricosanoic acid

22-oxo-tricosanoic acid

C23H44O3 (368.329)


   

3-oxo-tricosanoic acid

3-oxo-tricosanoic acid

C23H44O3 (368.329)


   

(R)-3,4-Dihydro-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol

2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol

C25H36O2 (368.2715)


   

12'-Apo-b-carotene-3,12'-diol

4-[(1E,3Z,5E,7E,9E,11Z)-13-hydroxy-3,7,12-trimethyltrideca-1,3,5,7,9,11-hexaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol

C25H36O2 (368.2715)


   

(E)-26,27-Dinorergosta-4,22-dien-3-one

2,15-dimethyl-14-[(3E)-5-methylhex-3-en-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C26H40O (368.3079)


   

gamma-Eudesmol rhamnoside

2-{[2-(4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-yl]oxy}-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

Stearyl fumarate

(2Z)-4-(octadecyloxy)-4-oxobut-2-enoic acid

C22H40O4 (368.2926)


   

1,13-Diphenoxytridecane

1,1'-[1,13-Tridecanediylbis(oxy)]bisbenzene, 9CI

C25H36O2 (368.2715)


   

FA 23:1;O

22-oxo-tricosanoic acid

C23H44O3 (368.329)


   

FA 21:3;O3

9S,11R,15R-trihydroxy-15-methyl-5Z,13E-prostadienoic acid

C21H36O5 (368.2563)


   

WE 22:2;O2

(2Z)-4-(octadecyloxy)-4-oxobut-2-enoic acid

C22H40O4 (368.2926)


   

FAHFA 22:1;O

3-(7Z-tetradecenoyloxy)-octanoic acid

C22H40O4 (368.2926)


   

Cortol

Pregnane-3,11,17,20,21-pentol,(3a,5b,11b,20S)-

C21H36O5 (368.2563)


   

beta-Cortol

5beta-Pregnane-3alpha,11beta,17,20R,21-pentol

C21H36O5 (368.2563)


   

ST 21:0;O5

5alpha-pregnane-3alpha,11beta,17,20R,21-pentol

C21H36O5 (368.2563)


   

5-((7Z,10Z,13Z,16Z)-nonadeca-7,10,13,16-tetraen-1-yl)resorcinol

5-((7Z,10Z,13Z,16Z)-nonadeca-7,10,13,16-tetraen-1-yl)benzene-1,3-diol

C25H36O2 (368.2715)


   

Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N,N-dicyclohexyl- (9CI)

Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N,N-dicyclohexyl- (9CI)

C22H32N4O (368.2576)


   

N-[2-[(2-hydroxyethyl)amino]ethyl]octadecenamide

N-[2-[(2-hydroxyethyl)amino]ethyl]octadecenamide

C22H44N2O2 (368.3403)


   

trimesitylborane

trimesitylborane

C27H33B (368.2675)


   
   

2,2-(3,5,5-trimethylhexylidene)bis[4,6-dimethylphenol]

2,2-(3,5,5-trimethylhexylidene)bis[4,6-dimethylphenol]

C25H36O2 (368.2715)


   

Phosphoric acid, octadecyl ester

Phosphoric acid, octadecyl ester

C18H41O5P (368.2691)


   

4-((5,6-diphenylpyrazin-2-yl)(perdeutero-propan-2-yl)amino)butan-1-ol

4-((5,6-diphenylpyrazin-2-yl)(perdeutero-propan-2-yl)amino)butan-1-ol

C23H20D7N3O (368.2593)


   

cyclohexane-1,2-diyl bis(2-ethylhexanoate)

cyclohexane-1,2-diyl bis(2-ethylhexanoate)

C22H40O4 (368.2926)


   

(16S,20S)-Pregnan-3beta,5alpha,6beta,16,20-pentaol

(16S,20S)-Pregnan-3beta,5alpha,6beta,16,20-pentaol

C21H36O5 (368.2563)


   

2-[4-N-(HEXYLOXY)PHENYL]-5-N-OCTYLPYRIMIDINE

2-[4-N-(HEXYLOXY)PHENYL]-5-N-OCTYLPYRIMIDINE

C24H36N2O (368.2827)


   

Monostearyl fumarate

Monostearyl fumarate

C22H40O4 (368.2926)


   

Cholesta-3,5-diene

Cholesta-3,5-diene

C27H44 (368.3443)


   

19-Norcholesta-1,3,5(10)-trien-3-ol

19-Norcholesta-1,3,5(10)-trien-3-ol

C26H40O (368.3079)


A 3-hydroxy steroid that is 19-norcholesta-1,3,5(10)-triene substituted by a hydroxy group at position 3. It is isolated from Hainan soft coral Dendronephthya studeri.

   
   

Nocrac NS 5

2-tert-butyl-6-[(3-tert-butyl-5-ethyl-2-hydroxy-phenyl)methyl]-4-ethyl-phenol

C25H36O2 (368.2715)


   
   

(3R,17R)-17-(1,2-dihydroxyethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,11,17-triol

(3R,17R)-17-(1,2-dihydroxyethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,11,17-triol

C21H36O5 (368.2563)


   

Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, (11alpha,13E)-(+-)-

Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, (11alpha,13E)-(+-)-

C21H36O5 (368.2563)


   

15-methyl PGF2alpha

15-methyl PGF2alpha

C21H36O5 (368.2563)


   

Pgt-2A,methyl ester

Pgt-2A,methyl ester

C21H36O5 (368.2563)


   

(E)-7alpha-Methyl-4-((Z)-2-(2-methylenecyclohexylidene)ethylidene)-1-(6-methylheptan-2-yl)octahydro-1H-indene

(E)-7alpha-Methyl-4-((Z)-2-(2-methylenecyclohexylidene)ethylidene)-1-(6-methylheptan-2-yl)octahydro-1H-indene

C27H44 (368.3443)


   

MG(18:2(10E,12Z)+=O(9)/0:0/0:0)

MG(18:2(10E,12Z)+=O(9)/0:0/0:0)

C21H36O5 (368.2563)


   

MG(18:2(9Z,11E)+=O(13)/0:0/0:0)

MG(18:2(9Z,11E)+=O(13)/0:0/0:0)

C21H36O5 (368.2563)


   

MG(0:0/18:2(10E,12Z)+=O(9)/0:0)

MG(0:0/18:2(10E,12Z)+=O(9)/0:0)

C21H36O5 (368.2563)


   

[(2S)-2,3-dihydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-2,3-dihydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C21H36O5 (368.2563)


   

[(2S)-2,3-dihydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-2,3-dihydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C21H36O5 (368.2563)


   

1,3-dihydroxypropan-2-yl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

1,3-dihydroxypropan-2-yl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C21H36O5 (368.2563)


   

1,3-dihydroxypropan-2-yl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

1,3-dihydroxypropan-2-yl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C21H36O5 (368.2563)


   

[3-carboxy-2-[(5Z,8Z)-tetradeca-5,8-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5Z,8Z)-tetradeca-5,8-dienoyl]oxypropyl]-trimethylazanium

C21H38NO4+ (368.2801)


   

[(2S)-3-carboxy-2-[(3E,5E)-tetradeca-3,5-dienoyl]oxypropyl]-trimethylazanium

[(2S)-3-carboxy-2-[(3E,5E)-tetradeca-3,5-dienoyl]oxypropyl]-trimethylazanium

C21H38NO4+ (368.2801)


   

[3-carboxy-2-[(10E,12E)-tetradeca-10,12-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(10E,12E)-tetradeca-10,12-dienoyl]oxypropyl]-trimethylazanium

C21H38NO4+ (368.2801)


   

[3-carboxy-2-[(6E,9E)-tetradeca-6,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(6E,9E)-tetradeca-6,9-dienoyl]oxypropyl]-trimethylazanium

C21H38NO4+ (368.2801)


   

[3-carboxy-2-[(2E,4E)-tetradeca-2,4-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,4E)-tetradeca-2,4-dienoyl]oxypropyl]-trimethylazanium

C21H38NO4+ (368.2801)


   

[(4E,6E)-2-(carboxymethyl)-2-hydroxy-3-oxohexadeca-4,6-dienyl]-trimethylazanium

[(4E,6E)-2-(carboxymethyl)-2-hydroxy-3-oxohexadeca-4,6-dienyl]-trimethylazanium

C21H38NO4+ (368.2801)


   

(6a)-21,21-O-dihydroophiobolin G

(6a)-21,21-O-dihydroophiobolin G

C25H36O2 (368.2715)


   

N-icosanoylglycinate

N-icosanoylglycinate

C22H42NO3- (368.3165)


   

(3R)-3-hydroxy-12-apo-beta-carotenol

(3R)-3-hydroxy-12-apo-beta-carotenol

C25H36O2 (368.2715)


   

Hinesol beta-D-fucopyranoside, (rel)-

Hinesol beta-D-fucopyranoside, (rel)-

C21H36O5 (368.2563)


A natural product found in Carthamus oxyacantha.

   

5-(Hydroxymethyl)-3-(1-oxohexadecyl)oxolane-2,4-dione

5-(Hydroxymethyl)-3-(1-oxohexadecyl)oxolane-2,4-dione

C21H36O5 (368.2563)


   

N-oleoyl-L-serinate

N-oleoyl-L-serinate

C21H38NO4- (368.2801)


An N-acyl-L-alpha-amino acid anion resulting from the deprotonation of the carboxy group of N-oleoyl-L-serine. The major species at pH 7.3.

   

(2S)-2-(hexadecanoylamino)-4-methylpentanoate

(2S)-2-(hexadecanoylamino)-4-methylpentanoate

C22H42NO3- (368.3165)


   

[(1S)-3-carboxy-1-[(3E,5E)-tetradeca-3,5-dienoyl]oxypropyl]-trimethylazanium

[(1S)-3-carboxy-1-[(3E,5E)-tetradeca-3,5-dienoyl]oxypropyl]-trimethylazanium

C21H38NO4+ (368.2801)


   

3-Methyl-6-nonyl-6-(tetrahydro-2H-pyran-2-yloxymethyl)tetrahydro-2H-pyran-2,4-dione

3-Methyl-6-nonyl-6-(tetrahydro-2H-pyran-2-yloxymethyl)tetrahydro-2H-pyran-2,4-dione

C21H36O5 (368.2563)


   

Fahfa 18:1/4:0

Fahfa 18:1/4:0

C22H40O4 (368.2926)


   

2,4,6-Tri-tert-butyl-1-tert-butyldifluorosilylbenzene

2,4,6-Tri-tert-butyl-1-tert-butyldifluorosilylbenzene

C22H38F2Si (368.2711)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] propanoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] propanoate

C22H40O4 (368.2926)


   

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] acetate

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] acetate

C22H40O4 (368.2926)


   

1-(2-Hydroxy-3-methoxyphenyl)-12-phenyldodecane

1-(2-Hydroxy-3-methoxyphenyl)-12-phenyldodecane

C25H36O2 (368.2715)


   

[3-carboxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropyl]-trimethylazanium

C21H38NO4+ (368.2801)


   

(1-acetyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-acetyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C21H36O5 (368.2563)


   

2,3-dihydroxypropyl (9Z,12Z)-nonadeca-9,12-dienoate

2,3-dihydroxypropyl (9Z,12Z)-nonadeca-9,12-dienoate

C22H40O4 (368.2926)


   

Fahfa 17:1/5:0

Fahfa 17:1/5:0

C22H40O4 (368.2926)


   

Fahfa 2:0/20:1

Fahfa 2:0/20:1

C22H40O4 (368.2926)


   

Fahfa 6:0/16:1

Fahfa 6:0/16:1

C22H40O4 (368.2926)


   

Fahfa 13:1/9:0

Fahfa 13:1/9:0

C22H40O4 (368.2926)


   

Fahfa 15:1/7:0

Fahfa 15:1/7:0

C22H40O4 (368.2926)


   

Fahfa 4:0/18:1

Fahfa 4:0/18:1

C22H40O4 (368.2926)


   

Fahfa 16:1/6:0

Fahfa 16:1/6:0

C22H40O4 (368.2926)


   

Fahfa 14:1/8:0

Fahfa 14:1/8:0

C22H40O4 (368.2926)


   

Fahfa 3:0/19:1

Fahfa 3:0/19:1

C22H40O4 (368.2926)


   

Fahfa 9:0/13:1

Fahfa 9:0/13:1

C22H40O4 (368.2926)


   

Fahfa 7:0/15:1

Fahfa 7:0/15:1

C22H40O4 (368.2926)


   

Fahfa 19:1/3:0

Fahfa 19:1/3:0

C22H40O4 (368.2926)


   

Fahfa 5:0/17:1

Fahfa 5:0/17:1

C22H40O4 (368.2926)


   

Fahfa 8:0/14:1

Fahfa 8:0/14:1

C22H40O4 (368.2926)


   

2-[(Z)-icos-11-enoyl]oxyacetic acid

2-[(Z)-icos-11-enoyl]oxyacetic acid

C22H40O4 (368.2926)


   

(2R)-2-[(14S)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

(2R)-2-[(14S)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

C21H36O5 (368.2563)


   

Octadecyl fumarate

monostearyl maleate (100 mg)

C22H40O4 (368.2926)


   
   

12-Apo-b-carotene-3,12-diol

12-Apo-b-carotene-3,12-diol

C25H36O2 (368.2715)


   

Prostaglandin F2alpha methyl ester

Prostaglandin F2alpha methyl ester

C21H36O5 (368.2563)


   

15-methyl-15S-Prostaglandin E1

15-methyl-15S-Prostaglandin E1

C21H36O5 (368.2563)


   

15-methyl-15R-PGF2alpha

15-methyl-15R-PGF2alpha

C21H36O5 (368.2563)


   

(5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene

(5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene

C27H44 (368.3443)


   

beta-Allocortol

beta-Allocortol

C21H36O5 (368.2563)


   

alpha-Allocortol

alpha-Allocortol

C21H36O5 (368.2563)


   

docosanedioate(2-)

docosanedioate(2-)

C22H40O4 (368.2926)


A dicarboxylic acid dianion obtained by deprotonation of both carboxy groups of docosanedioic acid; major species at pH 7.3.

   

DG(18:2)

DG(8:0_10:2)

C21H36O5 (368.2563)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hydroxytricosenoic acid

Hydroxytricosenoic acid

C23H44O3 (368.329)


   

Pentacosaheptaenoic acid

Pentacosaheptaenoic acid

C25H36O2 (368.2715)


   

NA-Arg 14:1(9Z)

NA-Arg 14:1(9Z)

C19H36N4O3 (368.2787)


   

NA-Asn 16:1(9Z)

NA-Asn 16:1(9Z)

C20H36N2O4 (368.2675)


   

NA-Gln 15:1(9Z)

NA-Gln 15:1(9Z)

C20H36N2O4 (368.2675)


   

NA-Lys 15:1(9Z)

NA-Lys 15:1(9Z)

C21H40N2O3 (368.3039)


   

NA-Orn 16:1(9Z)

NA-Orn 16:1(9Z)

C21H40N2O3 (368.3039)


   

NA-Tryptamine 14:1(9Z)

NA-Tryptamine 14:1(9Z)

C24H36N2O (368.2827)


   

FAHFA 10:0/O-12:1

FAHFA 10:0/O-12:1

C22H40O4 (368.2926)


   

FAHFA 10:1/O-12:0

FAHFA 10:1/O-12:0

C22H40O4 (368.2926)


   

FAHFA 11:0/O-11:1

FAHFA 11:0/O-11:1

C22H40O4 (368.2926)


   

FAHFA 11:1(10E)/3O-11:0

FAHFA 11:1(10E)/3O-11:0

C22H40O4 (368.2926)


   

FAHFA 11:1/O-11:0

FAHFA 11:1/O-11:0

C22H40O4 (368.2926)


   

FAHFA 12:0/O-10:1

FAHFA 12:0/O-10:1

C22H40O4 (368.2926)


   

FAHFA 12:1(5Z)/3O-10:0

FAHFA 12:1(5Z)/3O-10:0

C22H40O4 (368.2926)


   

FAHFA 12:1/O-10:0

FAHFA 12:1/O-10:0

C22H40O4 (368.2926)


   

FAHFA 13:0/O-9:1

FAHFA 13:0/O-9:1

C22H40O4 (368.2926)


   

FAHFA 13:1(12E)/3O-9:0

FAHFA 13:1(12E)/3O-9:0

C22H40O4 (368.2926)


   

FAHFA 13:1/O-9:0

FAHFA 13:1/O-9:0

C22H40O4 (368.2926)


   

FAHFA 14:0/O-8:1

FAHFA 14:0/O-8:1

C22H40O4 (368.2926)


   

FAHFA 14:1(9Z)/3O-8:0

FAHFA 14:1(9Z)/3O-8:0

C22H40O4 (368.2926)


   

FAHFA 14:1/O-8:0

FAHFA 14:1/O-8:0

C22H40O4 (368.2926)


   

FAHFA 16:1(9Z)/3O-6:0

FAHFA 16:1(9Z)/3O-6:0

C22H40O4 (368.2926)


   

FAHFA 8:0/O-14:1

FAHFA 8:0/O-14:1

C22H40O4 (368.2926)


   

FAHFA 8:1/O-14:0

FAHFA 8:1/O-14:0

C22H40O4 (368.2926)


   

FAHFA 9:0/O-13:1

FAHFA 9:0/O-13:1

C22H40O4 (368.2926)


   

FAHFA 9:1/O-13:0

FAHFA 9:1/O-13:0

C22H40O4 (368.2926)


   

Deoxy-vitamin D3

Deoxy-vitamin D3

C27H44 (368.3443)


   
   

ST 26:3;O

ST 26:3;O

C26H40O (368.3079)


   

6,10-dimethyl-4'-(4-methylpent-3-en-1-yl)-3a,4,5,8,9,11a-hexahydrospiro[cyclodeca[b]furan-3,1'-cyclohexan]-3'-en-2-one

6,10-dimethyl-4'-(4-methylpent-3-en-1-yl)-3a,4,5,8,9,11a-hexahydrospiro[cyclodeca[b]furan-3,1'-cyclohexan]-3'-en-2-one

C25H36O2 (368.2715)


   

(2r)-2,3-dihydroxypropyl (10e,12z)-9-oxooctadeca-10,12-dienoate

(2r)-2,3-dihydroxypropyl (10e,12z)-9-oxooctadeca-10,12-dienoate

C21H36O5 (368.2563)


   

methyl (2e)-2-[(1s)-1-hydroxy-2-oxopropyl]octadec-2-enoate

methyl (2e)-2-[(1s)-1-hydroxy-2-oxopropyl]octadec-2-enoate

C22H40O4 (368.2926)


   

(2r,3s)-2-[(14r)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

(2r,3s)-2-[(14r)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

C21H36O5 (368.2563)


   

(2s)-2,3-dihydroxypropyl 9-oxooctadeca-10,12-dienoate

(2s)-2,3-dihydroxypropyl 9-oxooctadeca-10,12-dienoate

C21H36O5 (368.2563)


   

(1r,3as,3br,9as,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhepta-4,6-dien-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthrene

(1r,3as,3br,9as,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhepta-4,6-dien-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthrene

C27H44 (368.3443)


   

[(3r,4r,6s)-6-[(1e,4s)-2,4-diethyloct-1-en-1-yl]-4,6-diethyl-1,2-dioxan-3-yl]acetic acid

[(3r,4r,6s)-6-[(1e,4s)-2,4-diethyloct-1-en-1-yl]-4,6-diethyl-1,2-dioxan-3-yl]acetic acid

C22H40O4 (368.2926)


   

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H40O (368.3079)


   

(2s,3s)-2-[(14r)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

(2s,3s)-2-[(14r)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

C21H36O5 (368.2563)


   

(1r,3ar,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

(1r,3ar,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H40O (368.3079)


   

4-hydroxy-5-(hydroxymethyl)-3-(14-methylpentadecanoyl)-5h-furan-2-one

4-hydroxy-5-(hydroxymethyl)-3-(14-methylpentadecanoyl)-5h-furan-2-one

C21H36O5 (368.2563)


   

(1r,3s,7r,8e,11s,12r)-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

(1r,3s,7r,8e,11s,12r)-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H36O2 (368.2715)


   

(2s,3r,4s,5r,6r)-2-({2-[(2r,4as)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-({2-[(2r,4as)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

(3r,4e,6s,7r,8e,10e,12s,13e)-4,6,8,10,12-pentamethyl-14-phenyltetradeca-4,8,10,13-tetraene-3,7-diol

(3r,4e,6s,7r,8e,10e,12s,13e)-4,6,8,10,12-pentamethyl-14-phenyltetradeca-4,8,10,13-tetraene-3,7-diol

C25H36O2 (368.2715)


   

(4r,5r)-4,5-dihydroxy-5-(1-hydroxyheptadecyl)cyclopent-2-en-1-one

(4r,5r)-4,5-dihydroxy-5-(1-hydroxyheptadecyl)cyclopent-2-en-1-one

C22H40O4 (368.2926)


   

(1r,3s,4s,7r,8e,11s,12s,13s,16s)-1,4,16-trimethyl-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadeca-5,8-diene-8-carboxylic acid

(1r,3s,4s,7r,8e,11s,12s,13s,16s)-1,4,16-trimethyl-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadeca-5,8-diene-8-carboxylic acid

C25H36O2 (368.2715)


   

4,6,8,10,12-pentamethyl-14-phenyltetradeca-4,8,10,13-tetraene-3,7-diol

4,6,8,10,12-pentamethyl-14-phenyltetradeca-4,8,10,13-tetraene-3,7-diol

C25H36O2 (368.2715)


   

abridin

NA

C25H36O2 (368.2715)


{"Ingredient_id": "HBIN014234","Ingredient_name": "abridin","Alias": "NA","Ingredient_formula": "C25H36O2","Ingredient_Smile": "CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO","Ingredient_weight": "368.55","OB_score": "21.01357769","CAS_id": "73030-56-5","SymMap_id": "SMIT00712","TCMID_id": "12","TCMSP_id": "MOL007683","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

agallochin m

NA

C21H36O5 (368.2563)


{"Ingredient_id": "HBIN014811","Ingredient_name": "agallochin m","Alias": "NA","Ingredient_formula": "C21H36O5","Ingredient_Smile": "CC1(CCC2C(O1)(CC(C(C2(C)CCC(=O)OC)C(C)(C)O)O)C)C=C","Ingredient_weight": "368.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "693","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101232173","DrugBank_id": "NA"}

   

alpha-bisabolol beta-d-fucopyranoside

NA

C21H36O5 (368.2563)


{"Ingredient_id": "HBIN015411","Ingredient_name": "alpha-bisabolol beta-d-fucopyranoside ","Alias": "NA","Ingredient_formula": "C21H36O5","Ingredient_Smile": "CC1C(C(C(C(O1)OC(C)(CCC=C(C)C)C2CCC(=CC2)C)O)O)O","Ingredient_weight": "368.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19480","PubChem_id": "102286643","DrugBank_id": "NA"}

   

(2s,3r,4r,5r,6s)-2-({2-[(2r,4ar)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

(2s,3r,4r,5r,6s)-2-({2-[(2r,4ar)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

1,4,16-trimethyl-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadeca-5,8-diene-8-carboxylic acid

1,4,16-trimethyl-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadeca-5,8-diene-8-carboxylic acid

C25H36O2 (368.2715)


   

4,5-dihydroxy-5-(1-hydroxyheptadecyl)cyclopent-2-en-1-one

4,5-dihydroxy-5-(1-hydroxyheptadecyl)cyclopent-2-en-1-one

C22H40O4 (368.2926)


   

2-[(2-{6,10-dimethylspiro[4.5]dec-6-en-2-yl}propan-2-yl)oxy]-6-methyloxane-3,4,5-triol

2-[(2-{6,10-dimethylspiro[4.5]dec-6-en-2-yl}propan-2-yl)oxy]-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

methyl (1s,2s,3r,6r,7r,10s,11s,12s)-2-[(8e)-dec-8-en-1-yl]tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl (1s,2s,3r,6r,7r,10s,11s,12s)-2-[(8e)-dec-8-en-1-yl]tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C25H36O2 (368.2715)


   

methyl 3-[2-ethenyl-7-hydroxy-6-(2-hydroxypropan-2-yl)-2,5,8a-trimethyl-hexahydro-1-benzopyran-5-yl]propanoate

methyl 3-[2-ethenyl-7-hydroxy-6-(2-hydroxypropan-2-yl)-2,5,8a-trimethyl-hexahydro-1-benzopyran-5-yl]propanoate

C21H36O5 (368.2563)


   

(2s,3r,4s,5r,6r)-2-({2-[(2s,5s,10r)-6,10-dimethylspiro[4.5]dec-6-en-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-({2-[(2s,5s,10r)-6,10-dimethylspiro[4.5]dec-6-en-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

(1r,3s,4s,7r,11s,12r,13s,16s)-1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

(1r,3s,4s,7r,11s,12r,13s,16s)-1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

C25H36O2 (368.2715)


   

(1r,3ar,7s,9ar,9bs,11ar)-1-[(2r,3e)-hept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

(1r,3ar,7s,9ar,9bs,11ar)-1-[(2r,3e)-hept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H40O (368.3079)


   

methyl 3-[(2r,4as,5s,6r,7r,8as)-2-ethenyl-7-hydroxy-6-(2-hydroxypropan-2-yl)-2,5,8a-trimethyl-hexahydro-1-benzopyran-5-yl]propanoate

methyl 3-[(2r,4as,5s,6r,7r,8as)-2-ethenyl-7-hydroxy-6-(2-hydroxypropan-2-yl)-2,5,8a-trimethyl-hexahydro-1-benzopyran-5-yl]propanoate

C21H36O5 (368.2563)


   

methyl 3-methyl-5-(1,6,7-trihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl)pent-2-enoate

methyl 3-methyl-5-(1,6,7-trihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl)pent-2-enoate

C21H36O5 (368.2563)


   

2-(14-hydroxypentadecyl)-4-methyl-5-oxo-2h-furan-3-carboxylic acid

2-(14-hydroxypentadecyl)-4-methyl-5-oxo-2h-furan-3-carboxylic acid

C21H36O5 (368.2563)


   

methyl 2-(1-hydroxy-2-oxopropyl)octadec-9-enoate

methyl 2-(1-hydroxy-2-oxopropyl)octadec-9-enoate

C22H40O4 (368.2926)


   

3-(hydroxymethyl)-6-(2-hydroxytetradecan-2-yl)-4-methoxypyran-2-one

3-(hydroxymethyl)-6-(2-hydroxytetradecan-2-yl)-4-methoxypyran-2-one

C21H36O5 (368.2563)


   

(2r,3r,4s,5r,6s)-2-methyl-6-{[(2s)-6-methyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-yl]oxy}oxane-3,4,5-triol

(2r,3r,4s,5r,6s)-2-methyl-6-{[(2s)-6-methyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-yl]oxy}oxane-3,4,5-triol

C21H36O5 (368.2563)


   

1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

C25H36O2 (368.2715)


   

methyl 2-(dec-8-en-1-yl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

methyl 2-(dec-8-en-1-yl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate

C25H36O2 (368.2715)


   

(2s)-2,3-dihydroxypropyl (10e,12e)-9-oxooctadeca-10,12-dienoate

(2s)-2,3-dihydroxypropyl (10e,12e)-9-oxooctadeca-10,12-dienoate

C21H36O5 (368.2563)


   

[6-(2,4-diethyloct-1-en-1-yl)-4,6-diethyl-1,2-dioxan-3-yl]acetic acid

[6-(2,4-diethyloct-1-en-1-yl)-4,6-diethyl-1,2-dioxan-3-yl]acetic acid

C22H40O4 (368.2926)


   

3-hexadecanoyl-4-hydroxy-5-(hydroxymethyl)-5h-furan-2-one

3-hexadecanoyl-4-hydroxy-5-(hydroxymethyl)-5h-furan-2-one

C21H36O5 (368.2563)


   

(9s)-3,9-dihydroxy-16,17-dimethoxytricyclo[12.3.1.1²,⁶]nonadecan-7-one

(9s)-3,9-dihydroxy-16,17-dimethoxytricyclo[12.3.1.1²,⁶]nonadecan-7-one

C21H36O5 (368.2563)


   

(1s,2e,4e,6s,7r,12s,14r,20s,22s,27r)-15,19-diazapentacyclo[18.7.0.0⁶,¹⁴.0⁷,¹².0²²,²⁷]heptacosa-2,4-diene

(1s,2e,4e,6s,7r,12s,14r,20s,22s,27r)-15,19-diazapentacyclo[18.7.0.0⁶,¹⁴.0⁷,¹².0²²,²⁷]heptacosa-2,4-diene

C25H40N2 (368.3191)


   

(3r,3as,11ar)-6,10-dimethyl-4'-(4-methylpent-3-en-1-yl)-3a,4,5,8,9,11a-hexahydrospiro[cyclodeca[b]furan-3,1'-cyclohexan]-3'-en-2-one

(3r,3as,11ar)-6,10-dimethyl-4'-(4-methylpent-3-en-1-yl)-3a,4,5,8,9,11a-hexahydrospiro[cyclodeca[b]furan-3,1'-cyclohexan]-3'-en-2-one

C25H36O2 (368.2715)


   

(2r)-2-[(14s)-14-hydroxypentadecyl]-4-methyl-5-oxo-2h-furan-3-carboxylic acid

(2r)-2-[(14s)-14-hydroxypentadecyl]-4-methyl-5-oxo-2h-furan-3-carboxylic acid

C21H36O5 (368.2563)


   

(2r,3s)-2-[(14s)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

(2r,3s)-2-[(14s)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

C21H36O5 (368.2563)


   

2-methyl-6-{[6-methyl-2-(4-methylcyclohex-3-en-1-yl)hept-5-en-2-yl]oxy}oxane-3,4,5-triol

2-methyl-6-{[6-methyl-2-(4-methylcyclohex-3-en-1-yl)hept-5-en-2-yl]oxy}oxane-3,4,5-triol

C21H36O5 (368.2563)


   

1-(hept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

1-(hept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C26H40O (368.3079)


   

(1r,3s,4s,7r,8e,11s,12r,13s,16s)-1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

(1r,3s,4s,7r,8e,11s,12r,13s,16s)-1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

C25H36O2 (368.2715)


   

(2s,3s,4s,5r,6s)-2-({2-[(2r,5s,10s)-6,10-dimethylspiro[4.5]dec-6-en-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

(2s,3s,4s,5r,6s)-2-({2-[(2r,5s,10s)-6,10-dimethylspiro[4.5]dec-6-en-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

(1s,3r,4r,7s,8e,11r,12r,13r,16r)-1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

(1s,3r,4r,7s,8e,11r,12r,13r,16r)-1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

C25H36O2 (368.2715)


   

(4r,6r)-6-hexadecyl-4-hydroxy-4,6-dimethyloxan-2-one

(4r,6r)-6-hexadecyl-4-hydroxy-4,6-dimethyloxan-2-one

C23H44O3 (368.329)


   

methyl 2-(1-hydroxy-2-oxopropyl)octadec-2-enoate

methyl 2-(1-hydroxy-2-oxopropyl)octadec-2-enoate

C22H40O4 (368.2926)


   
   

8-(hydroxymethyl)-1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)tricyclo[9.3.0.0³,⁷]tetradeca-4,8-dien-6-one

8-(hydroxymethyl)-1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)tricyclo[9.3.0.0³,⁷]tetradeca-4,8-dien-6-one

C25H36O2 (368.2715)


   

(2r)-2,3-dihydroxypropyl (10e,12e)-9-oxooctadeca-10,12-dienoate

(2r)-2,3-dihydroxypropyl (10e,12e)-9-oxooctadeca-10,12-dienoate

C21H36O5 (368.2563)


   

4-methyl-5-oxo-2-(14-oxopentadecyl)oxolane-3-carboxylic acid

4-methyl-5-oxo-2-(14-oxopentadecyl)oxolane-3-carboxylic acid

C21H36O5 (368.2563)


   

(2r,3r,4s,5r,6s)-2-methyl-6-{[(2r)-6-methyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-yl]oxy}oxane-3,4,5-triol

(2r,3r,4s,5r,6s)-2-methyl-6-{[(2r)-6-methyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-yl]oxy}oxane-3,4,5-triol

C21H36O5 (368.2563)


   

(4r,5r)-4,5-dihydroxy-5-[(1s)-1-hydroxyheptadecyl]cyclopent-2-en-1-one

(4r,5r)-4,5-dihydroxy-5-[(1s)-1-hydroxyheptadecyl]cyclopent-2-en-1-one

C22H40O4 (368.2926)


   

(2s,3r,4s,5r,6r)-2-{[(4r,5r,6r,7s,10r)-7-isopropyl-4,10-dimethyltricyclo[4.4.0.0¹,⁵]decan-4-yl]oxy}-6-methyloxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-{[(4r,5r,6r,7s,10r)-7-isopropyl-4,10-dimethyltricyclo[4.4.0.0¹,⁵]decan-4-yl]oxy}-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

n-{7-isopropyl-2,10-dimethylspiro[4.5]dec-6-en-2-yl}-n'-(2-phenylethyl)carbamimidic acid

n-{7-isopropyl-2,10-dimethylspiro[4.5]dec-6-en-2-yl}-n'-(2-phenylethyl)carbamimidic acid

C24H36N2O (368.2827)


   

(2r)-2,3-dihydroxypropyl (9e,11e)-13-oxooctadeca-9,11-dienoate

(2r)-2,3-dihydroxypropyl (9e,11e)-13-oxooctadeca-9,11-dienoate

C21H36O5 (368.2563)


   

(2s,3r,4s,5r,6s)-2-{[(1r,4r,5r,6r,7s,10r)-7-isopropyl-4,10-dimethyltricyclo[4.4.0.0¹,⁵]decan-4-yl]oxy}-6-methyloxane-3,4,5-triol

(2s,3r,4s,5r,6s)-2-{[(1r,4r,5r,6r,7s,10r)-7-isopropyl-4,10-dimethyltricyclo[4.4.0.0¹,⁵]decan-4-yl]oxy}-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

(2s,3r,4s,5r,6r)-2-{[(1s,4as,7r,8as)-1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-6-methyloxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-{[(1s,4as,7r,8as)-1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

2-decyl-5-(nona-1,3-diyn-1-yl)benzene-1,3-diol

2-decyl-5-(nona-1,3-diyn-1-yl)benzene-1,3-diol

C25H36O2 (368.2715)


   

methyl 3-[(2r,4as,5s,6r,7s,8as)-2-ethenyl-7-hydroxy-6-(2-hydroxypropan-2-yl)-2,5,8a-trimethyl-hexahydro-1-benzopyran-5-yl]propanoate

methyl 3-[(2r,4as,5s,6r,7s,8as)-2-ethenyl-7-hydroxy-6-(2-hydroxypropan-2-yl)-2,5,8a-trimethyl-hexahydro-1-benzopyran-5-yl]propanoate

C21H36O5 (368.2563)


   

(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-6-methyloxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)


   

2,3-dihydroxypropyl (9e,11e)-13-oxooctadeca-9,11-dienoate

2,3-dihydroxypropyl (9e,11e)-13-oxooctadeca-9,11-dienoate

C21H36O5 (368.2563)


   

1,4-dimethyl-12-(6-methylhept-5-en-2-yl)-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

1,4-dimethyl-12-(6-methylhept-5-en-2-yl)-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H36O2 (368.2715)


   

methyl (2z)-5-[(1s,2r,4as,6s,7r,8as)-1,6,7-trihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

methyl (2z)-5-[(1s,2r,4as,6s,7r,8as)-1,6,7-trihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

C21H36O5 (368.2563)


   

(2s,3r)-2-[(14s)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

(2s,3r)-2-[(14s)-14-hydroxypentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

C21H36O5 (368.2563)


   

2-(14-hydroxypentadecyl)-4-methylidene-5-oxooxolane-3-carboxylic acid

2-(14-hydroxypentadecyl)-4-methylidene-5-oxooxolane-3-carboxylic acid

C21H36O5 (368.2563)


   

n-[(2s,5r,10s)-7-isopropyl-2,10-dimethylspiro[4.5]dec-6-en-2-yl]-n'-(2-phenylethyl)carbamimidic acid

n-[(2s,5r,10s)-7-isopropyl-2,10-dimethylspiro[4.5]dec-6-en-2-yl]-n'-(2-phenylethyl)carbamimidic acid

C24H36N2O (368.2827)


   

(1r,2e,4e,6r,7s,12r,14s,20s,22r,27s)-15,19-diazapentacyclo[18.7.0.0⁶,¹⁴.0⁷,¹².0²²,²⁷]heptacosa-2,4-diene

(1r,2e,4e,6r,7s,12r,14s,20s,22r,27s)-15,19-diazapentacyclo[18.7.0.0⁶,¹⁴.0⁷,¹².0²²,²⁷]heptacosa-2,4-diene

C25H40N2 (368.3191)


   

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H40O (368.3079)


   

(2r)-2,3-dihydroxypropyl (9z,11e)-13-oxooctadeca-9,11-dienoate

(2r)-2,3-dihydroxypropyl (9z,11e)-13-oxooctadeca-9,11-dienoate

C21H36O5 (368.2563)


   

(2s,3r,4s)-4-methyl-5-oxo-2-(14-oxopentadecyl)oxolane-3-carboxylic acid

(2s,3r,4s)-4-methyl-5-oxo-2-(14-oxopentadecyl)oxolane-3-carboxylic acid

C21H36O5 (368.2563)


   

2,3-dihydroxypropyl 13-oxooctadeca-9,11-dienoate

2,3-dihydroxypropyl 13-oxooctadeca-9,11-dienoate

C21H36O5 (368.2563)


   

(2e,6r)-2-methyl-6-[(1s,2r,3r,4r,11s,15s)-4-methyl-12-methylidenetetracyclo[9.4.0.0²,⁴.0³,⁸]pentadec-7-en-15-yl]hept-2-enoic acid

(2e,6r)-2-methyl-6-[(1s,2r,3r,4r,11s,15s)-4-methyl-12-methylidenetetracyclo[9.4.0.0²,⁴.0³,⁸]pentadec-7-en-15-yl]hept-2-enoic acid

C25H36O2 (368.2715)


   

(4e,8e,10e,13e)-4,6,8,10,12-pentamethyl-14-phenyltetradeca-4,8,10,13-tetraene-3,7-diol

(4e,8e,10e,13e)-4,6,8,10,12-pentamethyl-14-phenyltetradeca-4,8,10,13-tetraene-3,7-diol

C25H36O2 (368.2715)


   

pgf2α methyl ester

pgf2α methyl ester

C21H36O5 (368.2563)


   

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-5-methylhex-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H40O (368.3079)


   

ethyl dec-4-enoate; obtusilic acid

ethyl dec-4-enoate; obtusilic acid

C22H40O4 (368.2926)


   

methyl (2e)-5-[(1s,2r,4as,6s,7r,8as)-1,6,7-trihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

methyl (2e)-5-[(1s,2r,4as,6s,7r,8as)-1,6,7-trihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

C21H36O5 (368.2563)


   

(1r,3s,8e,11s,12r)-8-(hydroxymethyl)-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradeca-4,8-dien-6-one

(1r,3s,8e,11s,12r)-8-(hydroxymethyl)-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradeca-4,8-dien-6-one

C25H36O2 (368.2715)


   

5-{n-[(2e)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]carbamimidamido}-2-(trimethylammonio)pentanoate

5-{n-[(2e)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]carbamimidamido}-2-(trimethylammonio)pentanoate

C19H36N4O3 (368.2787)


   

2-hydroxytricos-14-enoic acid

2-hydroxytricos-14-enoic acid

C23H44O3 (368.329)


   

2-methyl-6-({1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl}oxy)oxane-3,4,5-triol

2-methyl-6-({1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl}oxy)oxane-3,4,5-triol

C21H36O5 (368.2563)


   

methyl (2s,9z)-2-[(1r)-1-hydroxy-2-oxopropyl]octadec-9-enoate

methyl (2s,9z)-2-[(1r)-1-hydroxy-2-oxopropyl]octadec-9-enoate

C22H40O4 (368.2926)


   
   

(5r)-3-hexadecanoyl-4-hydroxy-5-(hydroxymethyl)-5h-furan-2-one

(5r)-3-hexadecanoyl-4-hydroxy-5-(hydroxymethyl)-5h-furan-2-one

C21H36O5 (368.2563)


   

(1r,3s,4s,7r,11s,12s,13s,16s)-1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

(1r,3s,4s,7r,11s,12s,13s,16s)-1,4,16-trimethyl-6-oxo-13-(prop-1-en-2-yl)tetracyclo[9.7.0.0³,⁷.0¹²,¹⁶]octadec-8-ene-8-carbaldehyde

C25H36O2 (368.2715)


   

2,3-dihydroxypropyl 9-oxooctadeca-10,12-dienoate

2,3-dihydroxypropyl 9-oxooctadeca-10,12-dienoate

C21H36O5 (368.2563)


   

2,3-dihydroxypropyl (10e)-9-oxooctadeca-10,12-dienoate

2,3-dihydroxypropyl (10e)-9-oxooctadeca-10,12-dienoate

C21H36O5 (368.2563)


   

2-{[1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-6-methyloxane-3,4,5-triol

2-{[1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-6-methyloxane-3,4,5-triol

C21H36O5 (368.2563)